A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 1,125,411 shares of BMY stock, worth $59.9 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,125,411
Previous 1,145,887 1.79%
Holding current value
$59.9 Million
Previous $62.1 Million 24.79%
% of portfolio
0.15%
Previous 0.21%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$40.25 - $52.99 $824,159 - $1.09 Million
-20,476 Reduced 1.79%
1,125,411 $46.7 Million
Q1 2024

May 03, 2024

SELL
$47.98 - $54.4 $498,800 - $565,542
-10,396 Reduced 0.9%
1,145,887 $62.1 Million
Q4 2023

Jan 24, 2024

SELL
$48.48 - $57.85 $1.95 Million - $2.33 Million
-40,254 Reduced 3.36%
1,156,283 $59.3 Million
Q3 2023

Oct 23, 2023

SELL
$57.89 - $64.73 $2.03 Million - $2.27 Million
-34,992 Reduced 2.84%
1,196,537 $69.4 Million
Q2 2023

Jul 25, 2023

SELL
$63.71 - $70.74 $1.82 Million - $2.02 Million
-28,613 Reduced 2.27%
1,231,529 $78.8 Million
Q1 2023

May 17, 2023

BUY
$65.71 - $74.53 $80.3 Million - $91.1 Million
1,222,119 Added 3214.16%
1,260,142 $87.3 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $79.5 Million - $90.2 Million
-1,209,642 Reduced 96.95%
38,023 $2.64 Billion
Q4 2022

Feb 09, 2023

SELL
$68.48 - $81.09 $5.54 Million - $6.56 Million
-80,856 Reduced 6.09%
1,247,665 $89.8 Million
Q3 2022

Nov 04, 2022

BUY
$0.13 - $76.84 $2,350 - $1.39 Million
18,084 Added 1.38%
1,328,521 $94.4 Million
Q2 2022

Aug 10, 2022

SELL
$72.62 - $79.98 $1.82 Million - $2.01 Million
-25,123 Reduced 1.88%
1,310,437 $101 Million
Q1 2022

Apr 27, 2022

SELL
$61.48 - $73.72 $1.29 Million - $1.55 Million
-20,974 Reduced 1.55%
1,335,560 $97.5 Million
Q4 2021

Jan 31, 2022

SELL
$53.63 - $62.52 $1.85 Million - $2.15 Million
-34,450 Reduced 2.48%
1,356,534 $84.6 Million
Q3 2021

Oct 20, 2021

SELL
$59.17 - $69.31 $3.48 Million - $4.08 Million
-58,814 Reduced 4.06%
1,390,984 $82.3 Million
Q2 2021

Jul 20, 2021

SELL
$61.91 - $67.42 $5 Million - $5.44 Million
-80,733 Reduced 5.27%
1,449,798 $96.9 Million
Q1 2021

Apr 22, 2021

SELL
$59.34 - $66.74 $7.47 Million - $8.4 Million
-125,855 Reduced 7.6%
1,530,531 $96.6 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $2.82 Million - $3.2 Million
-48,846 Reduced 2.86%
1,656,386 $103 Million
Q3 2020

Nov 06, 2020

SELL
$57.43 - $63.64 $9.87 Million - $10.9 Million
-171,859 Reduced 9.16%
1,705,232 $103 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $9.14 Million - $10.7 Million
-166,650 Reduced 8.15%
1,877,091 $110 Million
Q1 2020

May 13, 2020

BUY
$46.4 - $67.43 $1.3 Million - $1.89 Million
28,049 Added 1.39%
2,043,741 $114 Million
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $29.5 Million - $38.5 Million
599,177 Added 42.3%
2,015,692 $129 Million
Q3 2019

Nov 20, 2019

SELL
$42.77 - $50.71 $148,454 - $176,014
-3,471 Reduced 0.24%
1,416,515 $71.8 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $32,527 - $35,968
-729 Reduced 0.05%
1,419,986 $64.4 Million
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $798,488 - $952,098
17,697 Added 1.26%
1,420,715 $66 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $98,836 - $128,167
2,027 Added 0.14%
1,403,018 $72.9 Million
Q3 2018

Oct 23, 2018

SELL
$55.19 - $62.25 $2.03 Million - $2.28 Million
-36,700 Reduced 2.55%
1,400,991 $87 Million
Q2 2018

Aug 02, 2018

SELL
$50.53 - $62.98 $206,819 - $257,777
-4,093 Reduced 0.28%
1,437,691 $79.6 Million
Q1 2018

Apr 10, 2018

SELL
$59.92 - $68.98 $2.48 Million - $2.85 Million
-41,379 Reduced 2.79%
1,441,784 $91.2 Million
Q4 2017

Jan 22, 2018

SELL
$59.94 - $65.35 $517,701 - $564,427
-8,637 Reduced 0.58%
1,483,163 $90.9 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $82.4 Million - $95.1 Million
1,491,800
1,491,800 $95.1 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.